Clinical trial to evaluate safety of palbociclib drug in African American women with

[News]

The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions in Washington, DC, Maryland, Alabama and New Jersey.

More... (http://www.news-medical.net/news/20160707/Clinical-trial-to-evaluate-safety-of-palbociclib-drug-in-African-American-women-with-breast-cancer.aspx)